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2013, accepted Janbesity has been increasing in epidemic proportions, with a disproportionately higher increase in morbid or class
III obesity, and obesity adversely affects cardiovascular (CV) hemodynamics, structure, and function, as well as
increases the prevalence of most CV diseases. Progressive declines in physical activity over 5 decades have occurred
and have primarily caused the obesity epidemic. Despite the potential adverse impact of overweight and obesity,
recent epidemiological data have demonstrated an association of mild obesity and, particularly, overweight on
improved survival. We review in detail the obesity paradox in CV diseases where overweight and at least mildly
obese patients with most CV diseases seem to have a better prognosis than do their leaner counterparts. The
implications of cardiorespiratory ﬁtness with prognosis are discussed, along with the joint impact of ﬁtness and
adiposity on the obesity paradox. Finally, in light of the obesity paradox, the potential value of purposeful weight loss
and increased physical activity to affect levels of ﬁtness is reviewed. (J Am Coll Cardiol 2014;63:1345–54)
ª 2014 by the American College of Cardiology FoundationObesity has been increasing in epidemic proportions in both
adults and children over many decades, and recently, the
proportion of the population with more severe, or morbid,
obesity has increased to a greater extent than has overweight
and mild obesity (1–3). Currently, nearly 70% of adults are
classiﬁed as either overweight or obese as compared with
fewer than 40% just 40 years ago (3). One can argue about
the impact of overweight and mild obesity on overall
prognosis particularly without accounting for levels of
cardiorespiratory ﬁtness (ﬁtness). Nevertheless, very recent
high-proﬁle data have suggested obesity may account for
nearly 20% of overall mortality (4).
There are numerous adverse effects of overweight and
obesity on general and cardiovascular (CV) health (3). Clearly,
obesity worsens most of the major CV risk factors, includ-
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uary 6, 2014.and places a “heavy” burden on the heart, negatively affecting
ventricular structure and systolic and diastolic ventricular
function (3,5,6). Not surprisingly, obesity is associated with
the prevalence of most CV diseases, including hypertension,
coronary heart disease (CHD), heart failure (HF), and atrial
ﬁbrillation (AF) (3,5). Nevertheless, substantial data, mostly
published during the last decade, have demonstrated an
“obesity paradox,”where obese patients generally have a better
short- and long-term prognosis than do their leaner coun-
terparts with the same CV diseases (3,5).
This state-of-the-art paper brieﬂy reviews the patho-
physiology/hemodynamics of obesity, discusses possible
causes of the obesity epidemic, and reviews the changing
landscape of obesity on survival in the general population
and in those with CV diseases, including hypertension,
CHD, HF, and AF. Additionally, we discuss the impact of
severe or morbid obesity on prognosis, especially in light
of the obesity paradox noted at least in overweight and
mildly obese patients with CV diseases. We also discuss the
role of cardiorespiratory ﬁtness (ﬁtness) compared with
fatness, and implications of ﬁtness in the obesity paradox.
Finally, we brieﬂy review the impact of purposeful weight
reduction on prognosis, especially considering the obesity
paradox.
CV Pathophysiology/Hemodynamics
Overweight and obesity have many adverse effects on he-
modynamics and CV structure and function (Fig. 1,
Table 1) (5), which have been reviewed in detail elsewhere
Table 1 Effects of Obesity on Cardiac Performance
Hemodynamics
Increased blood volume
Increased stroke volume
Increased arterial pressure
Increased LV wall stress
Pulmonary artery hypertension
Cardiac structure
LV concentric remodeling
LV hypertrophy (eccentric and concentric)
Left atrial enlargement
RV hypertrophy
Cardiac function
LV diastolic dysfunction
Abbreviations
and Acronyms
AF = atrial ﬁbrillation
BF = body fat
BMI = body mass index
CHD = coronary heart
disease
CV = cardiovascular
HF = heart failure
LV = left ventricle/
ventricular
MET = metabolic equivalent
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1346(3,5). Obesity certainly increases
total blood volume, stroke vol-
ume, and cardiac output, so typi-
cally, systemic vascular resistance
in obesity is reduced for any
given level of blood pressure.
Although most of the increases
in cardiac output in obesity are
due to high stroke volume
(because heart rate is typically
not increased), occasionally, heart
rate may be slightly increased as
a result of increased activation
of the sympathetic nervous sys-LV systolic dysfunction
RV failure
Inﬂammation
Increased C-reactive protein
Overexpression of tumor necrosis factor
Neurohumoral
Insulin resistance and hyperinsulinemia
Leptin insensitivity and hyperleptinemia
Reduced adiponectin
Sympathetic nervous system activation
Activation of renin-angiotensin-aldosterone system
Overexpression of peroxisome proliferator-activator receptor
Cellular
Hypertrophy
Apoptosis
Fibrosis
Adapted with permission from Lavie et al. (5).
LV ¼ left ventricular; RV ¼ right ventricular.tem. The Frank-Starling curve in obesity is often shifted to
the left as a result of increases in ﬁlling pressure and volume,
which increases CV work, also leading to left ventricular
(LV) changes with dilation and LV hypertrophy. Addition-
ally, obesity can lead to enlargement of the left atrium, not
only from the increased circulating blood volume, but also
from alterations in LV diastolic ﬁlling (5,7). From multiple
mechanisms, obesity has adverse effects on both systolic
and, especially, diastolic ventricular function (8).
Etiologies of Obesity and Energy Balance
During recent years, the origins of the obesity epidemic have
been in considerable dispute (9,10). Regardless of this
debate, it is widely accepted that increments in body weight
and overall adiposity, at the most fundamental level, are the
result of chronic positive energy balance (i.e., energy
expenditure < energy intake) (11,12). There has been a
number of studies suggesting that energy or food intake is
largely, if not completely, responsible for the obesity
epidemic, essentially blaming much of the obesity epidemic
in the Westernized world on poor dietary choices (13–15).
One of the arguments to support this theory is that time
spent in leisure-time physical activity has remained essen-
tially unchanged in recent decades, thus leading to the
conclusion that obesity is solely due to excessive energy or
caloric intake (11). However, leisure-time physical activity
represents a relatively small portion of total time per week,
which is much more affected by occupation-related activity
and household management energy expenditure.
Recently, we have demonstrated very marked declines in
occupation-related physical activity during the last 5 decades
(Fig. 2) (11), with similar declines in household management
energy expenditure in women during this same time (Fig. 3)
(12,16). In fact, the typical woman now has an energy
expenditure that is more than 1,800 calories/week less than
that of 5 decades ago (12). Considering the fact that generally
100 calories are burned for every mile traveled by foot, the
typical woman would have to walk or run over 18 miles/week
to make up for this loss of household management energy
expenditure. This suggests that reductions in occupation-
related activity and energy expenditure, similar to householdmanagement energy expenditure in women, largely explain
the marked increased prevalence in obesity noted during
recent decades (Fig. 4) (11).
Importantly, because voluntary physical activity (e.g.,
housework, exercise) is the only major modiﬁable compo-
nent of total daily energy expenditure, these signiﬁcant re-
ductions are independent of the relatively nonmodiﬁable
components of total daily energy expenditure such as resting
metabolic rate (17), thermic effect of food (18), and non-
exercise activity thermogenesis (19,20).The Changing Landscape of Obesity
Recently, scientists have debated the impact of overweight
and obesity on overall chronic disease, including all-cause
mortality (21). In fact, it has been recently argued that
obesity is accounting for almost 1 in 5 deaths worldwide. (4)
On the other hand, Flegal and colleagues (21) have per-
formed a large meta-analysis of 97 studies in nearly 2.9
million people. They demonstrated that obesity, deﬁned by
standard body mass index (BMI) criteria (30 kg/m2), when
considering all grades, was associated with a signiﬁcantly
increased risk of mortality compared with normal BMI (18.5
to 25 kg/m2). However, the optimal survival occurred at the
Figure 1 Pathophysiology of Obesity Cardiomyopathy
This diagram shows the central hemodynamic, cardiac structural abnormalities, and alterations in ventricular function that may occur in severely obese patients and predispose
to heart failure. Left ventricular (LV) hypertrophy in severe obesity may be eccentric or concentric. In uncomplicated (normotensive) severe obesity, eccentric LV hypertrophy
predominates. In severely obese patients with long-standing systemic hypertension, concentric LV hypertrophy is frequently observed and may occur more commonly than
eccentric LV hypertrophy. Whether and to what extent metabolic disturbances such as lipotoxicity, insulin resistance, leptin resistance, and alterations of the renin-angiotensin-
aldosterone system contribute to obesity cardiomyopathy in humans is uncertain. RV ¼ right ventricular. Adapted with permission from Lavie et al. (5).
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1347overweight BMI (25 to 30 kg/m2); these patients had a
statistically signiﬁcant 6% lower mortality than did the
normal BMI cohort. Additionally, the mildly obese or class I
obese (BMI: 30 to 35 kg/m2) patients, had a 5% lower
mortality than did the normal BMI group, although this did
not reach statistical signiﬁcance. The adverse effects of higher
BMI on mortality are particularly noted in younger cohorts,
whereas higher BMI appears to be more protective in older
cohorts (22). Nevertheless, as mentioned previously, the
prevalence of more extreme degrees of obesity seem to be
increasing more so than is the prevalence of overweight and
mild obesity (1,2). In the Flegal et al. meta-analysis (21), the
contribution of class II obesity (BMI: 35 to 40 kg/m2)
and class III obesity (BMI: 40 kg/m2) exists and
appears particularly ominous, especially considering the
fact that class III or “morbid” obesity has been markedly
increasing, now approaching 3% prevalence in the United
States (1–3). Clearly, efforts to prevent and reverse these
severe degrees of obesity are needed, whereas the data to
support intervention in overweight and mild obesity are less
evident.Obesity Paradox
Despite the adverse impact of overweight and obesity on
most of the CV risk factors, as well as increasing the prev-
alence of most CV diseases, numerous studies during the
past decade demonstrate a clear obesity paradox, where
overweight and obese patients with CV diseases have a
better prognosis than do their leaner counterparts (3). The
mechanisms for this paradox are difﬁcult to reconcile, but
several potential mechanisms are listed in Table 2. Addi-
tionally, it has been argued that BMI, the typical method
used to assess obesity, has a poor diagnostic performance to
identify obesity in the general population and also in cohorts
with CHD (23–26), which may explain some, although not
all, of the paradoxes listed in this review. Therefore, we also
brieﬂy review the impact of other assessments of obesity,
including waist circumference and body fat (BF).
Hypertension. Obese patients have a higher prevalence of
hypertension compared with lean subjects, and obesity
adversely affects CHD risk factors and leads to increased
prevalence of LV hypertrophy, independent of arterial
Figure 2
Occupational METs and Energy Expenditure
Since 1960
The upper panel plots the mean occupation-related metabolic equivalents (METs)
since 1960, and the lower panel presents the mean occupational daily energy
expenditure in men and women since 1960. Reproduced with permission from
Church et al. (11).
Figure 3 Household Management Energy Expenditure per Week
This ﬁgure depicts the decade-to-decade change in household management energy expend
from Archer et al. (12).
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1348pressure. However, several studies demonstrate an obesity
paradox in hypertensive subjects. The largest of such
studies is from Uretsky et al. (27), who investigated the
effects of obesity on outcomes in 22,576 patients with
treated hypertension and with known CHD. Despite an
overall worse control of blood pressure during a 2-year
follow-up, all-cause mortality was 30% lower in over-
weight and obese hypertensive patients compared with
their lean counterparts. Other studies have either demon-
strated the same ﬁnding or demonstrated a U-shaped
relationship between BMI and all-cause, CV, and non-CV
mortality, being that excess mortality was noted at both
extremes of BMI (3). Certainly, overweight and mildly
obese hypertensive patients seem to have a better prognosis
than their leaner counterparts.
Coronary heart disease. Obesity plays a major role in
adversely affecting CHD risk factors and increasing the
prevalence of CHD (3), although some studies indicate that
CHD may not be increased in “metabolically healthy”
obesity (28–31). Nevertheless, as with hypertension, many
studies using various measures of adiposity, including BMI
(32–41), % BF (33–35), and some even with central obesity
or waist circumference (34), have demonstrated an obesity
paradox in CHD. Romero-Corral et al. (32) performed a
meta-analysis of 40 cohort studies in more than 250,000
patients with CHD and reported that overweight and obese
CHD patients have a lower risk of total and CV mortality
compared with underweight and normal-weight CHD pa-
tients. However, those authors demonstrated that in patients
with class II obesity (BMI: 35 to 40 kg/m2), there was aniture per week for all women and by employment status. Reproduced with permission
Figure 4 Predicted Weights and NHANES Weights
This ﬁgure presents the energy balance model–predicted mean U.S. bodyweight based on change in occupation-related daily energy expenditure since 1960 compared with
mean U.S. weight gain based on the National Health and Nutrition Examination Survey (NHANES) examination periods for 40- to 50-year-old men (top) and women (bottom).
Reproduced with permission from Church et al. (11).
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1349excess risk of CV mortality without any increase in total
mortality. Recently, some studies have demonstrated
an increased risk in CHD patients with “normal weight
obesity” and “normal weight central obesity”, in which % BF
or waist circumference, respectively, is high, although BMI
is in the normal range (31,36,37), whereas others have only
demonstrated this ﬁnding in those with low ﬁtness (dis-
cussed in the following text) (34).
Several recent studies have raised the possibility that
the association with lower adiposity and worse outcomesTable 2
Potential Reasons for the Obesity Paradox in
Cardiovascular Diseases
1. Nonpurposeful weight loss
2. Younger age at presentation
3. Lower prevalence of smoking
4. Greater metabolic reserves
5. Less cachexia
6. Lower atrial natriuretic peptides
7. Attenuated response to renin-angiotensin-aldosterone system
8. High blood pressure, allowing for more cardiac medications
9. Differing etiology, associated with a better prognosis
10. Increased muscle mass and muscular strength
11. Implications regarding cardiorespiratory ﬁtness
12. Unmeasured confounding factorsin CHD may represent as much as a “lean paradox” as an
obesity paradox (33,35,38,39). We have demonstrated
this obesity paradox with low BF (deﬁned as <25% in men
and <35% in women) and low BMI (33,40), and both low
BF and low BMI are independent predictors of worse out-
comes. However, in a study of 581 patients with CHD, we
demonstrated that only those with low BMI (<25 kg/m2)
and low BF had a high mortality rate compared with the
other groups (33). Most recently, we demonstrated that both
low BF and low lean mass (or nonfat mass) is associated with
the worst survival, patients with both high lean mass and BF
had the best survival, whereas intermediate survival rates
were noted in the other groups (Fig. 5) (35). Other studies
demonstrate that this may represent more of an “overweight
paradox,” where overweight CHD patients do particularly
well compared with lean (38,39).
Therefore, in CHD, it appears that there is a strong
obesity paradox, particularly with BMI, but also with BF
and central obesity, with the best prognosis noted in over-
weight CHD patients, as opposed to those with more severe
obesity (41).
Heart failure. Because obesity causes marked abnormalities
in LV structure and function (3,5), the increase in the
prevalence of HF with obesity is not surprising. Kenchaiah
et al. (42) studied 5,881 Framingham Heart Study partici-
pants and demonstrated a 5% increase in HF prevalence in
Figure 5 Body Composition and CHD Survival
Three-year survival based on body composition: low and high body fat (BF) and low and high lean mass index (LMI). Mortality was highest in the low BF/low LMI group (15%, or 9
of 62), followed by the high BF/low LMI group (5.7%, or 3 of 53), low BF/high LMI group (4.5%, or 8 of 179), and high BF/high LMI group (2.2%, or 6 of 270). CHD ¼ coronary
heart disease. Reproduced with permission from Lavie et al. (35).
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1350men and a 7% increase in women for every 1 kg/m2 increase
in BMI, with the risk of HF increasing across the entire
spectrum of BMI. However, in a study of 550 subjects
without diabetes, increased BMI was not associated with
increased risks of HF, whereas metabolic syndrome
increased the risk of HF by 2.5-fold. (43) In this study, in
contrast to normal weight patients with metabolic syndrome,
metabolically healthy obese subjects had a decreased HF risk
in a 6-year follow-up. However, a recent study from Norway
demonstrated that in contrast to CHD, metabolically
healthy obese patients still had an increased risk of HF (29).
Alpert et al. (44) demonstrated a very strong relationship
between morbid obesity and HF prevalence.
The obesity paradox in HF has recently been reviewed in
detail (5). In a meta-analysis of observational HF studies
(N ¼ 28,209), Oreopoulous et al. (45) demonstrated that
compared with patients with normal BMI, overweight and
obese HF patients had reductions in CV (19% and 40%,
respectively) and total mortality (16% and 33%, respec-
tively) during an average 2.7-year follow-up. The obesity
paradox in HF has been demonstrated with BMI, % BF,
and with waist circumference or central obesity (5,46–48).
Atrial ﬁbrillation. As with obesity, the prevalence of AF
has been increasing and is expected to increase by 2.5-fold
during the next 30 years (3). The increase in AF may be
partly due to the obesity epidemic, with its adverse hemo-
dynamic effects and the impact on LV and left atrial
structure and function (3,7). In a meta-analysis of 16 studies
of more than 120,000 patients, Wanahita et al. (49)
demonstrate that obese patients had a 50% increased risk
of developing AF. However, as in patients with hyperten-
sion, CHD, and HF, overweight and obese patients with
AF have a considerably better prognosis than do those
patients with normal BMI (3).Impact of Morbid Obesity
The prevalence of morbid or class III obesity (BMI40 kg/m2)
has been dramatically increasing, and is now present in close
to 3% of the United States population (1,2). Although an
obesity paradox exists, recent evidence suggests that this
does not typically apply to more morbid obesity, where
prognosis is adversely affected in acute CHD (50,51), CHD
patients undergoing revascularization (52,53), including
percutaneous intervention and coronary artery bypass graft-
ing, as well as in patients with HF (54,55). This level of
severe obesity is a major risk factor for development of CV
diseases and is associated with poor prognosis when CV
diseases become manifest. Therefore, efforts to prevent and
treat morbid obesity are urgently needed.
Impact of Cardiorespiratory Fitness
Fitness versus fatness. Body fatness and ﬁtness are strong
predictors of CV disease risk factors, as well as CV morbidity
and mortality (3,56–58). The relative and combined contri-
butions of ﬁtness and fatness to health are controversial,
but substantial evidence suggests that ﬁtness remains very
predictive and largely negates the adverse effects of body
fatness, as well as other traditional CV risk factors, including
overweight/obesity, metabolic syndrome/type II diabetes
mellitus, and hypertension (59–64). In most of these CV
disorders, patients with high ﬁtness have lower mortality
than do patients without these disorders, but with low levels
of ﬁtness. In a recent meta-analysis of 33 studies of more
than 100,000 participants, Kodama et al. (58) demonstrated
that for every 1 metabolic equivalent (MET) increase in
ﬁtness, all-cause mortality and CHD/CV events are reduced
by 13% and 15%, respectively. In 66,371 subjects without
prior CV disease from the Cooper Center Longitudinal
Figure 6 Obesity Paradox and Fitness in CHD
Joint effects of cardiorespiratory ﬁtness and BMI (A), waist circumference (WC)
(B), and % BF (C), on all-cause mortality. Hazard ratios (boxes) and 95% conﬁ-
dence intervals (error bars represent values) after adjusting for age, baseline ex-
amination year, physical activity (active or inactive), smoking (current smoker or
not), alcohol intake (>14 drinks/week or not), hypercholesterolemia, hyperten-
sion, and diabetes (present or not for each), and family history of cardiovascular
disease. Abbreviations as in Figure 5. Reproduced with permission from McAuley
et al. (34).
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1351Study, a single measure of ﬁtness signiﬁcantly improved
classiﬁcation of both 10-year and 25-year risks for CV
mortality when added to traditional CV risk factors (65).
In a study of 3,148 healthy adults, changes over time in
both adiposity (BMI and % BF) and ﬁtness predicted thedevelopment of hypertension, metabolic syndrome, and
hypercholesterolemia, but the impact of ﬁtness appears
somewhat better than did adiposity for future risk of these
CV disorders (66). In addition, a 1-MET increase in ﬁtness
on 2 maximal exercise stress tests separated by an average
of 6.3 years in 14,345 men was associated with reductions in
all-cause and CV mortality of 15% and 19%, respectively;
BMI change was not associated with all-cause and CV mor-
tality after adjusting for possible confounders and changes in
ﬁtness (67). The constellation of these data suggests that
although ideal prevention of both age-associated loss in ﬁtness
and increase in adiposity may be useful, maintaining or
improving ﬁtness is more important than preventing increased
adiposity with regard to long-term health outcomes.
Obesity paradox and ﬁtness. Several studies have sug-
gested that ﬁtness markedly alters the relationship between
adiposity and prognosis in both CHD and HF (34,68–70).
In a recent study of nearly 10,000 patients with CHD, only
those in the bottom 33rd percentile for age- and sex-related
levels of ﬁtness demonstrated an obesity paradox, which
was present by BMI, %BF, and even by waist circumference
or central obesity (Fig. 6) (34). On the other hand, CHD
patients without low ﬁtness had a good prognosis regardless
of their level of adiposity, so no obesity paradox was
apparent, which has been described elsewhere (71). We
recently demonstrated the same ﬁnding in 2,066 patients
with systolic HF; in fact, HF patients with peak oxygen
consumption <14 ml/kg/min had a poor prognosis, and a
strong obesity paradox was present, with obese (BMI: >30
kg/m2) having a better prognosis, lean (BMI: 18.5 to 25 kg/m2)
having a particularly poor prognosis, and overweight (BMI:
25 to 30 kg/m2) having an intermediate prognosis. On the
other hand, HF patients with relatively preserved ﬁtness
(peak oxygen consumption >14 ml/kg/min) had a good
overall prognosis regardless of BMI, and again no obesity
paradox was apparent (Fig. 7) (69). A recent study by
Uretsky et al. (72), however, of more than 5,000 patients
with normal nuclear perfusion stress tests, demonstrated that
an obesity paradox was maintained regardless of the level of
ﬁtness. Nevertheless, those with relatively preserved ﬁtness
(6 estimated METs) had an extremely low mortality rate
of <1% per year, although the normal BMI group had a
higher mortality rate (1.4%/year) compared with the over-
weight and obese groups (0.9%/year and 0.6%/year,
respectively) (72,73). None of these studies, however, have
adequately accessed the impact of ﬁtness on prognosis of
patients with severe obesity, particularly with class II and
class III obesity (BMI: 35 to 40 and >40 kg/m2, respec-
tively). It is noteworthy that in this latter group of patients,
assessing levels of ﬁtness can be challenging.
Role of Purposeful Weight Reduction
The role of purposeful weight reduction, except in the
morbidly obese patient, where obesity is particularly detri-
mental to health outcomes, continues to be controversial
Figure 7 Obesity Paradox and Fitness in HF
Kaplan-Meier analyses according to BMI with the low CRF group (O2 consumption <14 ml O2 kg
1 min1, log rank 11.7, p ¼ 0.003) and high CRF group (O2 consumption 14
ml O2 kg
1 min1, log rank 1.72, p ¼ 0.42) on the left and right, respectively. BMI ¼ body mass index; CRF ¼ cardiorespiratory ﬁtness; HF ¼ heart failure. Adapted from data in
Lavie et al. (69) and reproduced with permission from Lavie et al. (73).
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1352(3,5,74,75). Some long-term studies have suggested that
weight loss may be associated with increased mortality
(3,76), and coupled with the obesity paradox discussed in the
preceding text, it has been suggested that purposeful weight
loss can be detrimental. Clearly, however, lifestyle in-
terventions with diet and exercise training and at least mild
weight reduction have markedly reduced the prevalence of
metabolic syndrome and type II diabetes mellitus (77–79),
although a recent large study on diabetes did not demon-
strate survival beneﬁts from small amounts of weight loss in
diabetic subjects (80). In a CHD study of 530 patients that
demonstrated an obesity paradox, overweight and obese
patients who were successful with purposeful weight
reduction had a trend of lower mortality (40). In a study of
1,500 CHD patients, intentional weight loss produced a
lower incidence of CHD events over 4-year follow-up (81).
A small study of 377 CHD patients showed the beneﬁts
of weight loss on major CV events even in patients with
BMI <25 kg/m2 (82).
In hypertension, purposeful weight loss has resulted in
marked improvements in arterial pressure and LV geometry
(83). In HF, weight loss, especially with bariatric surgery,
has improved LV geometry, systolic and diastolic function,
and clinical symptoms (5). Currently, many severely obese
patients are being referred for bariatric surgery. Although
30-day mortality may be higher than ideal as a result of
surgeon inexperience (84), most studies in severely obese and
diabetic patients are showing improvements in short- and
long-term prognosis (3,85–89).
Although better large-scale weight loss intervention trials
are needed, the constellation of data still supports purposeful
weight reduction in patients with CV diseases, especially in
the more severely obesity (probably BMI >35 kg/m2 and
especially BMI >40 kg/m2). Considering the importance of
ﬁtness to improve prognosis in almost every patient groupstudied, including overweight and obese patients, as well as
the clear evidence that improvements in ﬁtness are associ-
ated with reductions in mortality in both CHD (33,90,91)
and HF (69,92), incorporating exercise training and efforts
to improve ﬁtness into weight loss programs appears to be
particularly beneﬁcial (93,94).Conclusions
Although obesity adversely affects CV risk factors and LV
structure and function, and is associated with increased
risk of most CV diseases, an obesity paradox exists showing
that overweight and obese patients with CV diseases have
a better prognosis than do their leaner counterparts. This
obesity paradox seems largely apparent in patients with
low ﬁtness, whereas those with better ﬁtness have a good
prognosis, and no clear obesity paradox is apparent. Although
better long-term intervention studies are needed, purposeful
weight reduction, and especially incorporating exercise trai-
ning and improvements in ﬁtness, seems to be beneﬁcial.
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